1. sp 2 -Iminosugar azobenzene O-glycosides: Light-sensitive glycosidase inhibitors with unprecedented tunability and switching factors.
- Author
-
Rivero-Barbarroja G, Carmen Padilla-Pérez M, Maisonneuve S, Isabel García-Moreno M, Tiet B, Vocadlo DJ, Xie J, García Fernández JM, and Ortiz Mellet C
- Subjects
- Humans, Dose-Response Relationship, Drug, Light, Molecular Structure, Structure-Activity Relationship, Glucosylceramidase chemistry, Glucosylceramidase metabolism, Glucosylceramidase pharmacology, Azo Compounds chemistry, Azo Compounds pharmacology, Azo Compounds chemical synthesis, Enzyme Inhibitors chemistry, Enzyme Inhibitors pharmacology, Enzyme Inhibitors chemical synthesis, Glycoside Hydrolases antagonists & inhibitors, Glycoside Hydrolases metabolism, Glycosides chemistry, Glycosides pharmacology, Glycosides chemical synthesis, Imino Sugars chemistry, Imino Sugars pharmacology, Imino Sugars chemical synthesis
- Abstract
The conventional approach to developing light-sensitive glycosidase activity regulators, involving the combination of a glycomimetic moiety and a photoactive azobenzene module, results in conjugates with differences in glycosidase inhibitory activity between the interchangeable E and Z-isomers at the azo group that are generally below one-order of magnitude. In this study, we have exploited the chemical mimic character of sp
2 -iminosugars to access photoswitchable p- and o-azobenzene α-O-glycosides based on the gluco-configured representative ONJ. Notably, we achieved remarkably high switching factors for glycosidase inhibition, favoring either the E- or Z-isomer depending on the aglycone structure. Our data also indicate a correlation between the isomeric state of the azobenzene module and the selectivity towards α- and β-glucosidase isoenzymes. The most effective derivative reached over a 103 -fold higher inhibitory potency towards human β-glucocerebrosidase in the Z as compared with the E isomeric form. This sharp contrast is compatible with ex-vivo activation and programmed self-deactivation at physiological temperatures, positioning it as a prime candidate for pharmacological chaperone therapy in Gaucher disease. Additionally, our results illustrate that chemical tailoring enables the engineering of photocommutators with the ability to toggle inhibition between α- and β-glucosidase enzymes in a reversible manner, thus expanding the versatility and potential therapeutic applications of this approach., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF